Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1984 1
1987 1
1991 1
1995 1
1996 2
2009 1
2018 4
2020 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Recommendations for cognitive screening and management in multiple sclerosis care.
Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, Gingold J, Goverover Y, Halper J, Harris C, Kostich L, Krupp L, Lathi E, LaRocca N, Thrower B, DeLuca J. Kalb R, et al. Among authors: lathi e. Mult Scler. 2018 Nov;24(13):1665-1680. doi: 10.1177/1352458518803785. Epub 2018 Oct 10. Mult Scler. 2018. PMID: 30303036 Free PMC article. Review.
Effectiveness of alternative dose fingolimod for multiple sclerosis.
Longbrake EE, Kantor D, Pawate S, Bradshaw MJ, von Geldern G, Chahin S, Cross AH, Parks BJ, Rice M, Khoury SJ, Yamout B, Zeineddine M, Russell-Giller S, Caminero-Rodriguez A, Edwards K, Lathi E, VanderKodde D, Meador W, Berkovich R, Ge L, Bacon TE, Kister I. Longbrake EE, et al. Among authors: lathi e. Neurol Clin Pract. 2018 Apr;8(2):102-107. doi: 10.1212/CPJ.0000000000000434. Neurol Clin Pract. 2018. PMID: 29708225 Free PMC article.
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis.
Money KM, Mahatoo A, Samaan S, Anand P, Baber U, Bailey M, Bakshi R, Bouley A, Bower A, Cahill J, Houtchens M, Katz J, Lathi E, Levit E, Longbrake EE, McAdams M, Napoli S, Raibagkar P, Wade P, Sloane JA. Money KM, et al. Among authors: lathi e. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 2;8(5):e1046. doi: 10.1212/NXI.0000000000001046. Print 2021 Sep. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34341094 Free PMC article.
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study.
Zivadinov R, Khan N, Korn JR, Lathi E, Silversteen J, Calkwood J, Kolodny S, Silva D, Medin J, Weinstock-Guttman B; MS-MRIUS study group. Zivadinov R, et al. Among authors: lathi e. Curr Med Res Opin. 2018 Aug;34(8):1431-1440. doi: 10.1080/03007995.2018.1458708. Epub 2018 Apr 12. Curr Med Res Opin. 2018. PMID: 29648900
Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study.
Weinstock-Guttman B, Medin J, Khan N, Korn JR, Lathi E, Silversteen J, Calkwood J, Silva D, Zivadinov R; MS-MRIUS Study Group. Weinstock-Guttman B, et al. Among authors: lathi e. CNS Drugs. 2018 Jan;32(1):75-84. doi: 10.1007/s40263-017-0482-4. CNS Drugs. 2018. PMID: 29270772 Free PMC article.
"Wrong-way eyes" in supratentorial hemorrhage.
Pessin MS, Adelman LS, Prager RJ, Lathi ES, Lange DJ. Pessin MS, et al. Among authors: lathi es. Ann Neurol. 1981 Jan;9(1):79-81. doi: 10.1002/ana.410090115. Ann Neurol. 1981. PMID: 7212670
17 results